AstraZeneca's Datroway Approved to Treat Non-Small Cell Lung Cancer in U.S.

  • The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a Phase 2 trial. The approval was also supported by data from a Phase 3 trial.